From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Pediatrics and Adolescent Medicine>
  4. Summary and Comment

Natural History of Thyroid-Stimulating Hormone in Children

Initially abnormal TSH levels tended to normalize within 5 years.

Few population-based data on thyroid function tests in children are available. Investigators in Israel determined the natural history of thyroid-stimulating hormone (TSH) using data from a health insurance administrative database. Of 1 million enrolled children (age range, 6 months to 16 years), 121,000 (12%) with no history of thyroid disease underwent TSH testing in 2002. The reason for testing was not specified in most cases.

On initial testing, TSH levels were normal (0.35–5.50 mIU/L) in 96.5% of children, mildly elevated (>5.50–10 mIU/L) in 2.9%, highly elevated (>10 mIU/L) in 0.4%, and low (<0.35 mIU/L) in 0.2%. After initial testing, treatment was started for overt thyroid dysfunction in 1% of children; data for these children were excluded from further analysis. About half the remaining children had second TSH tests during the next 5 years. Among those with low initial TSH levels, 79% had normal levels on the second test. Among those with mildly elevated and highly elevated initial TSH levels, 74% and 40%, respectively, had normal levels on the second test. Female sex and TSH level >10.0 mIU/L were significantly associated with persistently elevated TSH levels in multivariate analysis.

Comment: Apparently, routine TSH testing was common in this population of Israeli children. The findings suggest that about 1% of tests are likely to lead to a diagnosis of overt thyroid dysfunction and that most TSH abnormalities will normalize with time.

Howard Bauchner, MD

Published in Journal Watch Pediatrics and Adolescent Medicine June 3, 2009

Citation(s):

Lazar L et al. Natural history of thyroid function tests over 5 years in a large pediatric cohort. J Clin Endocrinol Metab 2009 May; 94:1678.

Reader Remarks:

Read all Reader Remarks on this article

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

(more...)

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.